Towards the integration of open-label extension and real-world evidence in ALS therapeutic evaluation? - 02/10/26
, A. Erazo b, P. Couratier b| ☆ | Considering his role as editor-in-chief, Philippe Couratier did not participate in the peer review process of this article and does not have access to information regarding the decision made. The full responsibility for the editorial process of this article has been delegated to the associate editor, Mathieu Anheim. |
| ☆☆ | Given his role as associate editor, Philippe Corcia was not involved in the peer review of this article and did not have access to information regarding the editorial decision. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
